2026-10-25
XMax clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 26,944 +1.18%
S&P 7,385 +0.42%
GOLD $4,067 −1.12%
BTC $75,586 −0.47%
VIX 25.28 −10.29%
latest tape · as of 18:01 UTC
The Screen · Consumer Cyclical · Furnishings, Fixtures & Appliances
XMax Inc
XMAX · NASDAQ · USD · Market cap $560M · 22 employees
XMax Inc., through its subsidiaries, designs, manufactures, markets, and sells residential and commercial furniture for middle and upper middle-income consumers North America, Hong Kong, and internationally.
Not yet scored5.00 USD
Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 18:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price5.00 USD at the 5 Nov 2026 close
- Our regime readDistribution, as of 5 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans heavily to calls (put/call 0.00)
- Last reviewed5 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: range not available (screen dated 2026-11-05).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.00, read 2026-10-29
- Ethical screen not yet scored
Price5.00 USD
Ethical score70.0/100
Our investment reviews on this name
2026-11-05Read Distribution5.22-4.2% to today ✓Markdown gives way to Distribution after a 19% slide in 4 days
2026-11-01Read Markdown6.42-22.1% to today ✓Accumulation gives way to Markdown after a 24% slide in 7 days
2026-10-25Read Accumulation8.48-41.0% to today Markdown gives way to Accumulation
2026-10-18Read Markdown8.48-41.0% to today ✓Accumulation gives way to Markdown first Markdown read since October
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its distribution label.
XMax Inc holds its Distribution at $5.00. Consolidating, no directional conviction, held for 265 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 265 days |
| Price at the screen | $5.00 |
| Valuation | 16.60 trailing · N/A forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 1.23 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 17.47% | Below 33% | Interest-bearing debt is just 17.5% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 25.75% | Below 49% | Money owed to the company is 25.8% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
XMax clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
XMax clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 17%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
The Business, in Plain Words| Trailing P/E | 16.6xreasonably valued |
| EPS, trailing | 0.52 |
| Revenue growth | +7.1%slow but positive growth |
| Profit margin | 185.9%highly profitable on every dollar of sales |
| Return on equity | 52.9%an exceptional return on shareholder capital |
| FCF yield | -0.46% |
| Debt to equity | 0.05minimal debt: a conservative balance sheet |
| Current ratio | 28.80comfortably covers its short-term bills |
| Beta | 1.23moves a little more than the market |
| Short interest, float | 0.14% |
| 52-week range | 4.80 - 9.40 |
| Moat | NONE |
| Market cap | $560M |
| Employees | 22 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeXMAX trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-05
Distribution · changed $5.22
+24.3% Entry 17
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 24.3% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 594%. Our forward projection puts the odds of a 10% gain over the next month near 43%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-04
Markdown $4.20
-34.6% Entry 16
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 34.6% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 594%. Our forward projection puts the odds of a 10% gain over the next month near 43%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03
Markdown $6.42
+0.0% Entry 15
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 594%. Our forward projection puts the odds of a 10% gain over the next month near 43%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02
Markdown $6.42
+0.0% Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 594%. Our forward projection puts the odds of a 10% gain over the next month near 43%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01
Markdown · changed $6.42
-25.9% Entry 13
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 25.9% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 594%. Our forward projection puts the odds of a 10% gain over the next month near 43%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31
Accumulation $8.66
+0.0% Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 594%. Our forward projection puts the odds of a 10% gain over the next month near 43%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30
Accumulation $8.66
+0.0% Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 594%. Our forward projection puts the odds of a 10% gain over the next month near 43%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29
Accumulation $8.66
+2.1% Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.1% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 594%. Our forward projection puts the odds of a 10% gain over the next month near 43%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25
Accumulation · changed $8.48
+0.0% Entry 9
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 5% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 594%. Our forward projection puts the odds of a 10% gain over the next month near 43%.
2026-10-18
Markdown · changed $8.48
-4.4% Entry 8
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 41% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 594%. Our forward projection puts the odds of a 10% gain over the next month near 43%.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Latest News In AI Chips - XMax Acquires Hexa Creation to Boost AI Power Solutions Yahoo Finance · 25d ago
- XMax to Acquire Hexa Creation, Developer of 1200V Vertical GaN Power Semiconductor Technology Yahoo Finance · 28d ago
- Sofas to AI Services? 2 Watchlist Stocks Yahoo Finance · 28 Sep 2026
- XMax Announces Cooperation with apM Group in Korea and Expansion into Vertical AI Applications Yahoo Finance · 17 Sep 2026
- The Zacks Analyst Blog Highlights Walmart, UnitedHealth, Wells Fargo, XMax and Interlink Electronics Zacks · 15 Sep 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
ETDEthan Allen Interiors Inc
HBBHamilton Beach Brands Holding Co
MBCMasterBrand, Inc.
FLXSFlexsteel Industries Inc
LOVELovesac Company
LZBLa-Z-Boy Incorporated
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $8.45 | +1.9% | · | $1,019 | +1.9% |
| 2 months | $7.21 | +19.4% | · | $1,194 | +19.4% |
| 3 months | $6.17 | +39.6% | · | $1,396 | +39.6% |
| 6 months | $5.93 | +45.2% | · | $1,452 | +45.2% |
| 1 year | $1.24 | +594.4% | · | $6,944 | +594.4% |
| 2 years | $1.66 | +418.7% | · | $5,187 | +418.7% |
| 3 years | $2.10 | +310.0% | · | $4,100 | +310.0% |
| 5 years | $15.55 | -44.6% | · | $554 | -44.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever XMAX does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.